JP2016517885A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016517885A5 JP2016517885A5 JP2016511809A JP2016511809A JP2016517885A5 JP 2016517885 A5 JP2016517885 A5 JP 2016517885A5 JP 2016511809 A JP2016511809 A JP 2016511809A JP 2016511809 A JP2016511809 A JP 2016511809A JP 2016517885 A5 JP2016517885 A5 JP 2016517885A5
- Authority
- JP
- Japan
- Prior art keywords
- formulation
- particles
- insulin
- agent
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000009472 formulation Methods 0.000 claims description 36
- 239000000203 mixture Substances 0.000 claims description 36
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims description 35
- 239000002245 particle Substances 0.000 claims description 24
- 229920000642 polymer Polymers 0.000 claims description 19
- 102000004877 Insulin Human genes 0.000 claims description 14
- 108090001061 Insulin Proteins 0.000 claims description 14
- 229940125396 insulin Drugs 0.000 claims description 14
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 11
- 239000008103 glucose Substances 0.000 claims description 11
- 239000003795 chemical substances by application Substances 0.000 claims description 10
- 239000011159 matrix material Substances 0.000 claims description 8
- 239000004026 insulin derivative Substances 0.000 claims description 7
- 102000016938 Catalase Human genes 0.000 claims description 6
- 108010053835 Catalase Proteins 0.000 claims description 6
- 108010015776 Glucose oxidase Proteins 0.000 claims description 6
- 239000004366 Glucose oxidase Substances 0.000 claims description 6
- 229940039227 diagnostic agent Drugs 0.000 claims description 6
- 239000000032 diagnostic agent Substances 0.000 claims description 6
- 229940116332 glucose oxidase Drugs 0.000 claims description 6
- 235000019420 glucose oxidase Nutrition 0.000 claims description 6
- 230000000069 prophylactic effect Effects 0.000 claims description 6
- 230000011664 signaling Effects 0.000 claims description 6
- 230000001225 therapeutic effect Effects 0.000 claims description 6
- 239000002105 nanoparticle Substances 0.000 claims description 5
- 239000002253 acid Substances 0.000 claims description 4
- 230000003345 hyperglycaemic effect Effects 0.000 claims description 4
- 239000003607 modifier Substances 0.000 claims description 4
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 claims description 3
- 239000008280 blood Substances 0.000 claims description 3
- 210000004369 blood Anatomy 0.000 claims description 3
- 108010004903 glycosylated serum albumin Proteins 0.000 claims description 3
- 208000001072 type 2 diabetes mellitus Diseases 0.000 claims description 3
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims description 2
- 229920001661 Chitosan Polymers 0.000 claims description 2
- 229940072056 alginate Drugs 0.000 claims description 2
- 229920000615 alginic acid Polymers 0.000 claims description 2
- 235000010443 alginic acid Nutrition 0.000 claims description 2
- 238000013270 controlled release Methods 0.000 claims description 2
- 239000003431 cross linking reagent Substances 0.000 claims description 2
- 230000000541 pulsatile effect Effects 0.000 claims description 2
- 238000000034 method Methods 0.000 description 6
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361817752P | 2013-04-30 | 2013-04-30 | |
| US61/817,752 | 2013-04-30 | ||
| US201361864069P | 2013-08-09 | 2013-08-09 | |
| US61/864,069 | 2013-08-09 | ||
| PCT/US2014/035927 WO2014179344A1 (en) | 2013-04-30 | 2014-04-29 | Injectable nano-network gels for diabetes treatment |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2016517885A JP2016517885A (ja) | 2016-06-20 |
| JP2016517885A5 true JP2016517885A5 (cg-RX-API-DMAC7.html) | 2017-06-15 |
Family
ID=51843897
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016511809A Pending JP2016517885A (ja) | 2013-04-30 | 2014-04-29 | 糖尿病を処置するための注射可能なナノネットワークゲル |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20160067190A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2991673A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2016517885A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20160024853A (cg-RX-API-DMAC7.html) |
| CN (1) | CN105813652A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2014260024B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112015027561A8 (cg-RX-API-DMAC7.html) |
| HK (2) | HK1222546A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2015015079A (cg-RX-API-DMAC7.html) |
| RU (1) | RU2015151135A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2014179344A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014153114A1 (en) * | 2013-03-14 | 2014-09-25 | Fred Hutchinson Cancer Research Center | Compositions and methods to modify cells for therapeutic objectives |
| JP2017538728A (ja) * | 2014-12-19 | 2017-12-28 | ケミン、インダストリーズ、インコーポレーテッドＫｅｍｉｎ Ｉｎｄｕｓｔｒｉｅｓ， Ｉｎｃ． | イオントフォレシスを用いた生物活性分子の眼内送達 |
| CN104740641B (zh) * | 2015-04-08 | 2019-02-01 | 烟台大学 | 一种糖敏感的缓控释微球组合物及其制备方法 |
| BR112017022535A2 (pt) * | 2015-04-21 | 2018-07-10 | Univ North Carolina State | sistema de liberação de insulina responsivo à glicose usando nanocompósitos sensíveis à hipóxia. |
| CN113730605A (zh) * | 2016-07-21 | 2021-12-03 | 波士顿科学国际有限公司 | 可注射组合物 |
| US11351230B2 (en) | 2016-11-07 | 2022-06-07 | North Carolina State University | Patch loaded with dual-sensitive vesicles for enhanced glucose-responsive insulin delivery |
| WO2018106696A1 (en) * | 2016-12-05 | 2018-06-14 | North Carolina State University | Core-shell microneedle devices and uses thereof |
| CN106668840B (zh) * | 2017-02-10 | 2020-02-14 | 南通大学 | 一种胰岛素控释药物及其制备方法与应用 |
| CN111343970A (zh) * | 2017-09-13 | 2020-06-26 | 北卡罗莱纳州立大学 | 微针贴片局部诱导脂肪组织褐变治疗肥胖症 |
| EP3713594A4 (en) | 2017-11-21 | 2021-11-03 | North Carolina State University | LOADABLE POLYMERIC DEPOT FOR GLUCOSE-TRIGGERED INSULIN DELIVERY WITH ULTRA-FAST REACTION |
| EP3735262A4 (en) * | 2018-01-03 | 2021-09-29 | Penn State Research Foundation | GLUCOSE OXIDASE COMPOSITIONS USED AS AN ANTI-CONVULSIVER IN NEWBORNS |
| CN111195238A (zh) * | 2018-10-31 | 2020-05-26 | 南方医科大学 | 一种用于胰岛素口服递送的聚电解质复合物 |
| WO2020219880A2 (en) * | 2019-04-25 | 2020-10-29 | Massachusetts Institute Of Technology | Cyclodextrin supramolecular scaffolds and uses thereof |
| CN115350267B (zh) * | 2022-07-19 | 2025-01-14 | 深圳大学 | 一种级联催化型纳米治疗剂及其制备方法和应用 |
| CN116474162B (zh) * | 2023-04-28 | 2024-08-16 | 吉林大学 | 一种用于糖尿病慢性创伤修复的自修复水凝胶的制备方法 |
| WO2025024243A1 (en) * | 2023-07-21 | 2025-01-30 | Massachusetts Institute Of Technology | Readily soluble and thermostable glucagon formulations and delivery for mini-dosing and closed-loop prophylactic treatment of hypoglycemia |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5359030A (en) * | 1993-05-10 | 1994-10-25 | Protein Delivery, Inc. | Conjugation-stabilized polypeptide compositions, therapeutic delivery and diagnostic formulations comprising same, and method of making and using the same |
| AU3360197A (en) * | 1996-07-01 | 1998-01-21 | Universiteit Utrecht | Hydrolysable hydrogels for controlled release |
| AU2003301064A1 (en) * | 2002-12-17 | 2004-07-14 | Massachusetts Institute Of Technology | Stimuli-responsive systems for controlled drug delivery |
| WO2006088473A2 (en) * | 2004-04-23 | 2006-08-24 | Panduranga Rao Koritala | Microcapsules and nanocapsules for the transmucosal delivery of therapeutic and diagnostic agents |
| EP1595534A1 (en) * | 2004-05-13 | 2005-11-16 | Universiteit Utrecht Holding B.V. | Gel composition comprising charged polymers |
| TWI394580B (zh) * | 2008-04-28 | 2013-05-01 | Halozyme Inc | 超快起作用胰島素組成物 |
| US20110189299A1 (en) * | 2008-07-01 | 2011-08-04 | Nitto Denko Corporation | Pharmaceutical composition containing surface-coated microparticles |
-
2014
- 2014-04-29 CN CN201480037463.3A patent/CN105813652A/zh active Pending
- 2014-04-29 HK HK16110684.2A patent/HK1222546A1/zh unknown
- 2014-04-29 JP JP2016511809A patent/JP2016517885A/ja active Pending
- 2014-04-29 HK HK16109650.4A patent/HK1221415A1/zh unknown
- 2014-04-29 BR BR112015027561A patent/BR112015027561A8/pt not_active Application Discontinuation
- 2014-04-29 EP EP14792285.0A patent/EP2991673A4/en not_active Withdrawn
- 2014-04-29 AU AU2014260024A patent/AU2014260024B2/en not_active Ceased
- 2014-04-29 MX MX2015015079A patent/MX2015015079A/es unknown
- 2014-04-29 WO PCT/US2014/035927 patent/WO2014179344A1/en not_active Ceased
- 2014-04-29 KR KR1020157034126A patent/KR20160024853A/ko not_active Withdrawn
- 2014-04-29 US US14/787,652 patent/US20160067190A1/en not_active Abandoned
- 2014-04-29 RU RU2015151135A patent/RU2015151135A/ru not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016517885A5 (cg-RX-API-DMAC7.html) | ||
| RU2015151135A (ru) | Инъекционные гелевые нанокаркасы для лечения диабета | |
| Asal et al. | Controlled synthesis of in-situ gold nanoparticles onto chitosan functionalized PLGA nanoparticles for oral insulin delivery | |
| Fattahpour et al. | Design and optimization of alginate− chitosan− pluronic nanoparticles as a novel meloxicam drug delivery system | |
| JP2008528446A5 (cg-RX-API-DMAC7.html) | ||
| US9101547B2 (en) | Enteric-coated capsule containing cationic nanoparticles for oral insulin delivery | |
| de Araújo et al. | Insulin-loaded poly (ε-caprolactone) nanoparticles: Efficient, sustained and safe insulin delivery system | |
| WO2015111062A1 (en) | Nanoencapsulation of hydrophilic active compounds | |
| WO2017100858A1 (en) | Polymer composite for controlled release of an agent | |
| Chevalier et al. | Non-covalently coated biopolymeric nanoparticles for improved tamoxifen delivery | |
| Shome et al. | Carboplatin loaded polymethylmethacrylate nano-particles in an adjunctive role in retinoblastoma: an animal trial | |
| US20200390884A1 (en) | Methods and Compositions for Modulating AKT3 | |
| WO2014077656A1 (ko) | 초기 약물 방출이 감소된 고분자 미립자를 포함하는 주사용 조성물 및 이의 제조방법 | |
| CN102908332A (zh) | 用于口服胰岛素递送的包含阳离子纳米粒子的肠溶包衣胶囊 | |
| AU2015301530A1 (en) | Compositions for inhibiting inflammation in a subject with a spinal cord injury and methods of using the same | |
| EP0468875B1 (fr) | Système matriciel autoadhésif pour la libération prolongée du piribédil par voie transcutanée | |
| CN106421807A (zh) | 一种载胰岛素羧甲基壳聚糖/壳聚糖纳米制剂的制备方法 | |
| TWI616210B (zh) | 經修飾微氣泡及其製備方法 | |
| Chaiyasan et al. | Development and characterization of topical ophthalmic formulations containing lutein-loaded mucoadhesive nanoparticles | |
| JP5080474B2 (ja) | タンパク質／ペプチドの経口送達のためのｐＨ感受性ナノ粒子製剤 | |
| Seekell et al. | Tunable polymer microcapsules for controlled release of therapeutic gases | |
| Silva et al. | Nanostructured polymeric system based of cashew gum for oral admnistration of insulin | |
| CN106267173B (zh) | 一种Cu/Zn SOD纳米颗粒及其制备方法与应用 | |
| Hatamie et al. | Carbohydrate Polymers, Polymeric Nano Drugs, and Nanoparticles Are Used for Advanced Drug Delivery and Therapeutics in Ocular Diseases | |
| Mukhopadhyay et al. | Stimuli-responsive polymers for oral insulin delivery |